Medtech Matters

In this episode of Medtech Matters, a podcast focused on the medical device manufacturing industry and the factors impacting it, we speak with Peter Vranes, co-founder and co-CEO of the Australian company Nutromics. He offers insight on a platform technology that enables continuous molecular monitoring. Using continuous glucose monitoring as an example for the potential for the technology, Vranes explains how his technology is capable of tracking any target, not just glucose. Specifically, the following questions are addressed.Your company has developed a continuous molecular monitoring platform. What does that mean exactly?Most people are aware of why you need to monitor glucose especially for diabetics but why seek to measure anything other than glucose continuously?How is your technology different from continuous glucose monitors already on the market?What is your first intended market for the technology and why did you choose it?Does the platform lend itself to be expanded to monitor other items such as w